TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,839.73−0.20%FTSE ADX9,832.27+0.50%TASI10,123.62−0.65%QE Index8,601.13−0.37%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,920.97−0.03%DFM:EMIRATESNBDAED 31.52+0.06%ADX:IHCAED 357.10+1.45%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.50−1.02%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.25−0.07%Gold$4,133.92−0.17%Brent$109.84+0.57%BTC$81,707.39−0.17%ETH$2,394.73−0.43%DFM General5,839.73−0.20%FTSE ADX9,832.27+0.50%TASI10,123.62−0.65%QE Index8,601.13−0.37%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,920.97−0.03%DFM:EMIRATESNBDAED 31.52+0.06%ADX:IHCAED 357.10+1.45%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.50−1.02%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.25−0.07%Gold$4,133.92−0.17%Brent$109.84+0.57%BTC$81,707.39−0.17%ETH$2,394.73−0.43%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralOpen 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralOpen 🇺🇸United StatesNasdaq · NYSE · S&P 500Closed 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Open

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Aktis Oncology Inc · Overview · TradingHolo

Markets › United States › NAS › AKTS

A

Aktis Oncology Inc

NAS:AKTSHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$15.06−5.93%At closeAt close · Sat 17 Oct · ≈ AED 55.31 · Market cap $837.63M · Next earnings Thu 12 Nov

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

−5.9%

1M

−34.1%

3M

−37.1%

6M

−25.6%

1Y

—

Why it's moving today

No company news in the last day; the move tracks its market and sector.

AKTS −5.93% today

✦ This week in three lines

No written digest yet for AKTS. The figures on this page are the source when one is written.

Financials

USD millions · annual3Y CAGR —

Valuation

P/E vs sector−13.1× vs −1.7×

Price / Book vs sector−5.7× vs 2.0×

Price / Sales vs sector128.9× vs 3.9×

Price / Free cash flow vs sector−11.4× vs −1.6×

Forecasts

9 buy0 hold0 sell9 analysts

Average target$36.00 +139.0%

Analysts2

EPS surprises, last 71 beat

Dividends

Yield0.0%

Annual payout—

Payout ratio0.0%

Next ex-date—

Years of growth—

Latest news

All AKTS news →

DOAktis Oncology Price Target Maintained With a $35.00/Share by Wedbush

Dow Jones Newswires · 18 d ago

TRWedbush reiterates Outperform rating on Aktis Oncology, $35 price target

TradingView · 18 d ago

GLAktis Oncology Initiates Second Phase 1b Clinical Trial for AKY-2519, a Miniprotein Radioconjugate Targeting B7-H3

GlobeNewswire · 19 d ago

Key facts

At close · Sat 17 Oct

Market cap (USD)$837.63M

P/E−13.1×

Dividend yield0.0%

52-week range$14.72 – $34.19

Avg volume (20d)388,401

Shares outstanding53,746,670

Beta0.45

Short interest15.0% of float

Next earningsThu 12 Nov

Radar Score

35

Value31

Quality41

Momentum24

Income45

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Aktis Oncology, Inc. is a clinical-stage biotechnology firm dedicated to advancing targeted radiopharmaceutical therapies for cancer treatment. Their core innovation lies in a proprietary miniprotein radioconjugate platform, which enables the discovery and development of potent radiopharmaceutical therapies designed…

SectorHealthcare

IndustryNormal

ExchangeNAS

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

57.3×+0.43%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

23.0×+0.90%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

119.3×+0.71%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

29.9×−1.29%